Invention Grant
- Patent Title: Methods of conditioning patients for T cell therapy
-
Application No.: US15950042Application Date: 2018-04-10
-
Publication No.: US11491187B2Publication Date: 2022-11-08
- Inventor: Adrian Bot , Jeffrey S. Wiezorek , William Go , Rajul Jain , James N. Kochenderfer , Steven A. Rosenberg
- Applicant: Kite Pharma, Inc. , United States of America, as represented by the Secretary, Department of Health and Human Services
- Applicant Address: US CA Santa Monica; US MD Rockville
- Assignee: Kite Pharma, Inc.,United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: Kite Pharma, Inc.,United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US CA Santa Monica; US MD Rockville
- Agency: Arrigo, Lee, Guttman & Mouta-Bellum, LLP
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K31/664 ; A61K31/7076 ; A61K31/675 ; A61K38/20 ; A61P35/02 ; A61K45/06
Abstract:
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.
Public/Granted literature
- US20180369283A1 METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY Public/Granted day:2018-12-27
Information query
IPC分类:
